Categories: HealthcareNews

B&D Capital Partners Advises MedShift

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

CHARLOTTE, N.C.–(BUSINESS WIRE)–B&D Capital Partners is pleased to announce the successful placement of an $89.5 million debt financing led by Huntington Bank and up to $200 million of capital commitments in a special purpose financing vehicle led by Stonehenge Structured Finance Partners and Blystone & Donaldson for MedShift, LLC. The initial transaction closed on October 18, 2024 and the combined $289.5m of total potential funding provides MedShift with access to sufficient capital to support its long term future growth.


This transaction emphasizes Huntington’s highly differentiated strategy of delivering national expertise locally and highlights a successful collaboration between local partners, including Blystone & Donaldson.

MedShift, a medical technology company founded in 2015 and headquartered in Charlotte, North Carolina, is a leader in the healthcare technology industry. The company caters to medical industry manufacturers as well as individual medical practices and providers across various markets, including dermatology, gynecology, plastic surgery, and medspa.

MedShift operates through three technology divisions (digitally automated credit underwriting/contracting, connected medical device, and enterprise SaaS), offering a comprehensive suite of innovative and cutting-edge software and hardware solutions. In addition, MedShift provides a range of complementary products and services, such as device consumables and injectables that streamline the complex supply-and-demand landscape, providing a highly differentiated and value-creating experience for both medical device suppliers and medical providers.

B&D Capital Partners, served as the financial advisor to the company and assisted in arranging, structuring, and negotiating the debt financing. B&D ultimately achieved the company’s objectives through a competitive process which included refinancing existing higher cost indebtedness, providing incremental liquidity to fund device purchases through the SPV, and securing more flexible debt service to allow management greater investment in the future growth of the business.

B&D Capital Partners is an affiliate of Blystone & Donaldson, LLC, a Charlotte, NC based investment firm with expertise and equity investments across several industries. B&D Capital Partners is a FINRA-registered broker-dealer and member of SIPC.

www.finra.org

www.sipc.org

Contacts

Jason Houseman

(716) 989-7708

Jason@bdcappartners.com

Staff

Recent Posts

NextPlat Corp Receives Nasdaq Notification Regarding Minimum Bid Requirements

COCONUT GROVE, Fla., April 28, 2025 /PRNewswire/ -- NextPlat Corp (NASDAQ: NXPL, NXPLW) ("NextPlat" or…

4 hours ago

TV STARS WALK THE WALK FROM COAST TO COAST AT PANCAN PURPLESTRIDE, THE ULTIMATE WALK TO END PANCREATIC CANCER

Reality Star Joan Vassos, "Star Trek" Team, Days of our Lives' Martha Madison & Cast Members…

4 hours ago

AI, Compliance, and Modernization Top Priorities for Healthcare IT Leaders in 2025, According to Info-Tech Research Group’s New Report

A new report from global research and advisory firm Info-Tech Research Group highlights the top…

4 hours ago

Hixny’s Snapshot Application Now Available to All Providers in New York

In a new SHIN-NY collaboration, Hixny has made it easy for providers across the stateto screen patients for HRSN and query the state's controlled substance database. ALBANY, N.Y., April 28, 2025 /PRNewswire/ -- Hixny,…

4 hours ago

CliniComp Launches Enterprise PACS, Fully Integrated into their New Era EHR with Intrinsic AI™

PACS fuels faster, more precise diagnosis and patient triaging for busy healthcare providers to assist…

4 hours ago